Valuation: Ha Tay Pharmaceutical

Market Cap 5,425B 206M 181M 169M 155M 291M 19.77B 295M 2.01B 783M 9.76B 774M 757M 33.74B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,524B 210M 185M 172M 158M 296M 20.13B 300M 2.04B 797M 9.94B 788M 771M 34.35B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day-0.66%
1 week-3.85%
Current month-7.85%
1 month-6.26%
3 months-14.43%
6 months-13.94%
Current year-14.43%
1 week 55,500
Extreme 55500
65,200
1 month 55,500
Extreme 55500
66,000
Current year 55,500
Extreme 55500
75,800
1 year 55,500
Extreme 55500
86,800
3 years 17,090.91
Extreme 17090.9091
100,818.18
5 years 11,980.52
Extreme 11980.5195
100,818.18
10 years 4,801.26
Extreme 4801.2593
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-3.85%-25.97%+132.01% 207M
+0.07%+4.22%+47.91%+162.71% 1,067B
+1.67%+7.60%+61.07%+54.14% 635B
-0.35%+2.10%+37.23%+73.81% 458B
+1.41%+8.56%+38.18%+32.17% 347B
+1.28%+4.40%+37.69%+41.62% 295B
+1.72%+4.10%+19.44%+20.45% 262B
+1.84%-0.46%-27.63%-38.65% 216B
+0.10%+3.18%+24.72%+59.19% 203B
+1.50%-1.49%+16.10%+71.52% 161B
Average +0.99%+1.24%+22.88%+60.90% 364.37B
Weighted average by Cap. +0.92%+1.95%+37.88%+78.41%

Financials

2024 2025
Net sales 2,086B 79.27M 69.69M 64.87M 59.58M 112M 7.6B 113M 771M 301M 3.75B 298M 291M 12.97B 2,402B 91.27M 80.24M 74.69M 68.59M 129M 8.75B 130M 888M 347M 4.32B 343M 335M 14.94B
Net income 71.77B 2.73M 2.4M 2.23M 2.05M 3.85M 262M 3.9M 26.53M 10.36M 129M 10.24M 10.02M 446M 53.66B 2.04M 1.79M 1.67M 1.53M 2.88M 196M 2.92M 19.83M 7.75M 96.54M 7.65M 7.49M 334M
Net Debt 290B 11.02M 9.68M 9.01M 8.28M 15.55M 1.06B 15.75M 107M 41.85M 522M 41.35M 40.46M 1.8B 98.73B 3.75M 3.3M 3.07M 2.82M 5.29M 360M 5.36M 36.49M 14.25M 178M 14.08M 13.78M 614M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
27/07/26 59,900.00 -0.66% 27,300
24/07/26 ₫60,300.00 +1.69% 11,352
23/07/26 ₫59,300.00 0.00% 1,300
22/07/26 ₫59,300.00 -0.50% 2,418
21/07/26 ₫59,600.00 -2.45% 4,310